Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Groceries can take a big chunk of your budget. Learn effective ways to save money on groceries and keep more cash in your pocket.
21,930 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Global equities outside the US have surged as growth improves and the dollar weakens. This article highlights three E...
When insider moves hit the headlines, investors seek clarity. This piece breaks down what it means when the holdings ...
Oil markets jump as Iran keeps Strait Hormuz under pressure, signaling potential disruption to energy flows. Investor...
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
In Q4 2025, mortgage originations hit $524 billion as lenders tighten standards, yet the real story lies in who quali...
HF Foods (HFFG) faces a pivotal year as Q1 2026 results unfold. This guide breaks down what to watch, how to interpre...
Brokerage mergers are reshaping the mortgage landscape as Compass International Holdings, Real, and eXp expand their ...
Mortgage rates have climbed to yearly highs as the 10-year yield advances, but housing demand remains positive due to...
NextEra Energy is pursuing a $67 billion all-stock deal to buy Dominion, aiming to create the world’s largest utility...
Greg Abel is guiding Berkshire Hathaway into a strategic cleanup phase. Discover the two key exits reportedly tied to...